MTNB vs VTGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTGN Captures Institutional Edge (2โ1 Pillars ยท 3โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vistagen Therapeutics, Inc. Common Stock (VTGN) driven by superior Growth & Margin, Options & Structure while MTNB counters with relative strength in Momentum & Technical. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VTGN at N/M Forward P/E and -2543.1% operating margin (-46.5% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTGN sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MTNB Revenue | VTGN Revenue | MTNB Op. Margin | VTGN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $0M | N/A | -21067.4% | N/A | MTNB |
| FY2020 | $0M | N/A | -15288.4% | N/A | MTNB |
| FY2021 | $0M | $0M | -74954.5% | -1646.1% | VTGN |
| FY2022 | $0M | $0M | -771.3% | -4308.3% | MTNB |
| FY2023 | $0M | N/A | -2168.4% | N/A | MTNB |
| FY2024 | N/A | $0M | N/A | -3103.5% | VTGN |
| FY2025 | N/A | $0M | N/A | -11517.1% | VTGN |
| FY2026 | N/A | $0M | N/A | -5683.7% | VTGN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTNB | VTGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $979,904 | $9.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | -46.5% | Higher Growth | VTGN |
| Operating Margin (TTM) Profitability | 0.0% | -2543.1% | Higher Margin | MTNB |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -147.5% | -144.9% | Higher ROE | VTGN |
| 52-Week Range Position Momentum | 22% ($0โ$3) | 0% ($0โ$5) | Stronger Trend | MTNB |
| Beta / 30D Volatility Risk Regime | -7.20ฮฒ ยท 147% Vol | 1.23ฮฒ ยท 80% Vol | Lower Realized Risk | VTGN |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 42.3 / 100 (HOLD) | Higher Composite | MTNB |